📊 Among patients with #STEMI undergoing primary percutaneous coronary intervention, roxadustat given after reperfusion did not reduce infarct size at 30 days vs standard care.
@jamanetworkopen.com
@jamanetworkopen.com📊 Among patients with #STEMI undergoing primary percutaneous coronary intervention, roxadustat given after reperfusion did not reduce infarct size at 30 days vs standard care.
@kensbookinfo.bsky.socialPublic #Health #News: #NewData Shows Tricog #Health's Seven-State #STEMI Programme is Catching Heart Attacks in Minutes and Lifting Survival - https://kensbookinfo.blogspot.com/p/health.html#7
@tumscvdri.bsky.social#MetabolicSyndrome is not one risk after #STEMI. In 6,060 primary #PCI patients, a continuous #MetS score predicted 1-year #MACE only in women <75 (HR 1.009/point; >112: HR 1.75)—not in men or those ≥75. link.springer.com/article/10.1...
@accintouch.bsky.socialCV experts are gathering in Medellín for #ACCLATAM 2026 to share new science, practical education and strategies to improve 🌎 heart health. From disparities & #STEMI outcomes to #AI & #cvPrev, the future of CV care is on the agenda: https://bit.ly/4xwbJJy @sccccardio
